awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q34198692-BD42E5C7-5513-4A98-96F5-E50CEFE01F0B
Q34198692-BD42E5C7-5513-4A98-96F5-E50CEFE01F0B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34198692-BD42E5C7-5513-4A98-96F5-E50CEFE01F0B
Update on developments with SGLT2 inhibitors in the management of type 2 diabetes
P2860
Q34198692-BD42E5C7-5513-4A98-96F5-E50CEFE01F0B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34198692-BD42E5C7-5513-4A98-96F5-E50CEFE01F0B
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
f0919e0859eaec45923326d209f28c0022d92c6b
P2860
Efficacy and safety of canagliflozin compared with placebo and sitagliptin in patients with type 2 diabetes on background metformin monotherapy: a randomised trial